1 not yet recruiting, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow CD8 PET Tracer: new trials by email Literature Review of CD8 PET Tracer trials Research Report on CD8 PET Tracer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001) MK-6255, CD8 PET Tracer, Acetaminophen - Ovarian Neoplasms, Endometrial Neoplasms | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 80 | 2026-11-13 | 2026-10-13 |
| A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001) MK-8294, CD8 PET Tracer - Metastatic Neoplasm | Phase 1 | Recruiting | Merck Sharp & Dohme LLC | 67 | 2025-07-23 | 2026-10-13 |
Endometrial Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Neoplasms (1)
Israel (1) · Netherlands (1) · United States (1)